COMP <GO>
PNTG vs ABBV // PIOTROSKI F-SCORE QUALITY
The Pennant Group Inc. (NASDAQ) VS. AbbVie Inc. (NYSE) • 15-METRIC TALLY: PNTG 3
— ABBV 8
■ METRIC PARITY
LAST: $42.48 (+0.76%) • MKT CAP: $1.48B
piotroski-score
7/9
LAST: $290.79 (+1.68%) • MKT CAP: $513.86B
piotroski-score
7/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PNTG VS. ABBV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PNTG | ABBV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 70.20% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 11.00% | 29.00% | -18.00 | ABBV | /roic <GO> |
| EV/EBITDA & P/E Valuation | 23.9x | 33.3x | -9.40 | PNTG | /valuation <GO> |
| Free Cash Flow Yield | 2.44% | 3.47% | -1.03 | ABBV | /fcf-yield <GO> |
| Operating Margin | 5.50% | 24.60% | -19.10 | ABBV | /operating-margins <GO> |
| Net Profit Margin | 3.10% | 6.90% | -3.80 | ABBV | /net-margins <GO> |
| Revenue Growth (YoY) | 36.30% | 8.60% | +27.70 | PNTG | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.27% | -2.27 | ABBV | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.81 | 5.33 | -2.52 | ABBV | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 53.6 | 65.1 | -11.49 | ABBV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.15 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 42.2x | 113.1x | -70.90 | PNTG | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.48B | $513.86B | -$512.38B | ABBV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PNTG REV | ABBV REV | PNTG GROSS % | ABBV GROSS % | PNTG FCF | ABBV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $947.7M | $61.16B | — | 70.2% | $36.3M | $17.82B |
| FY 2024 | $695.2M | $56.33B | — | 70.0% | $30.3M | $17.83B |
| FY 2023 | $544.9M | $54.32B | — | — | $33.1M | $20.39B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PNTG // BETA —
ABBV // BETA 1.15